Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: a systematic review and a meta-analysis

BMC Surgery

Jie Jiang²  Yanming Zhou¹  Lupeng Wu¹  Feng Ye¹  Haixing Luan³ 

[1] Department of Hepatobiliary & Pancreatovascular Surgery, Oncologic Center of Xiamen; First affiliated Hospital of Xiamen University, Xiamen 361003, China;Department of Thoracic Surgery, First affiliated Hospital of Xiamen University; Oncologic Center of Xiamen, Xiamen 361003, China;Department of Anesthesiology, First Hospital Affiliated to Xiamen University, Xiamen 361003, China

关键词: Meta-analysis;    Surgery;    Survival;    Blood transfusion;    Lung cancer;   

Others  :  863201
DOI  :  10.1186/1471-2482-14-34

 received in 2014-03-03, accepted in 2014-05-19,  发布年份 2014

【 摘 要 】

Background

It is speculated that blood transfusion may induce adverse consequences after cancer surgery due to immunosuppression. This study was intended to assess the impact of perioperative blood transfusion on the prognosis of patients who underwent lung cancer resection.

Methods

Eligible studies were identified through a computerized literature search. The pooled relative risk ratio (RR) with 95% confidence interval (CI) was calculated using Review Manager 5.1 Software.

Results

Eighteen studies with a total of 5915 participants were included for this meta-analysis. Pooled analysis showed that perioperative blood transfusion was associated with worse overall survival (RR: 1.25, 95% CI: 1.13-1.38; P <0.001) and recurrence-free survival (RR: 1.42, 95% CI: 1.20-1.67; P <0.001) in patients with resected lung cancer.

Conclusions

Perioperative blood transfusion appears be associated with a worse prognosis in patients undergoing lung cancer resection. These data highlight the importance of minimizing blood transfusion during surgery.

【 授权许可】

   
2014 Luan et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Gascon P, Zoumbos NC, Young NS: Immunological abnormalities in patients receiving multiple blood transfusions. Ann Intern Med 1984, 100:173-177.
• [2]Tartter PI, Burrows L, Kirschner P: Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset NO) non-oat cell lung cancer. J Thorac Cardiovasc Surg 1984, 88:659-662.
• [3]Hyman NH, Foster RS Jr, DeMeules JE, Costanza MC: Blood transfusions and survival after lung cancer resection. Am J Surg 1985, 149:502-507.
• [4]Moores DW, Piantadosi S, McKneally MF: Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann Thorac Surg 1989, 47:346-351.
• [5]Little AG, Wu HS, Ferguson MK, Ho CH, Bowers VD, Segalin A, Staszek VM: Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg 1990, 160:630-632.
• [6]Pastorino U, Valente M, Cataldo I, Lequaglie C, Ravasi G: Perioperative blood transfusion and prognosis of resected state Ia lung cancer. Eur J Cancer Clin Oncol 1986, 22:1375-1378.
• [7]Keller SM, Groshen S, Martini N, Kaiser LR: Blood transfusion and lung cancer recurrence. Cancer 1988, 62:606-610.
• [8]Pena CM, Rice TW, Ahmad M, Medendorp SV: The significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small cell lung cancers. Chest 1992, 102:84-87.
• [9]Rainio P, Bloigu R, Satta J, Pokela R, Paakko P: Ten-year survival after resection for lung carcinoma. effect of blood transfusion and tumour stage on outcome. Scand J Thor CardioVasc Surg 1996, 30:87-91.
• [10]Moher D, Liberati A, Tetzlaff J, Altman DG: PRISMA group: preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097.
• [11]Simillis C, Constantinides VA, Tekkis PP, Darzi A, Lovegrove R, Jiao L, Antoniou A: Laparoscopic versus open hepatic resections for benign and malignant neoplasms–a meta-analysis. Surgery 2007, 141:203-211.
• [12]Parmar MK, Torri V, Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17:2815-2834.
• [13]Piantadosi S, Moores DW, McKneally MF: The adverse effect of perioperative blood transfusion in lung cancer. Chest 1994, 106:382S-384S.
• [14]Nosotti M, Rebulla P, Riccardi D, Baisi A, Bellaviti N, Rosso L, Santambrogio L: Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer. Chest 2003, 124:102-107.
• [15]Rzyman W, Dziadziuszko R, Skokowski J, Wilimski R, Raiter A, Szymanowska A, Jassem J: The influence of blood transfusion on survival in operated non-small cell lung cancer patients. J Thorac Cardiovasc Surg 2003, 126:755-760.
• [16]Ghosh S, Ahmed K, Hopkinson DN, Vaughan R: Pulmonary adenocarcinoma is associated with poor long-term survival after surgical resection. effect of allogeneic blood transfusion. Cancer 2004, 101:2058-2066.
• [17]Berardi R, Brunelli A, Tamburrano T, Verdecchia L, Onofri A, Zuccatosta L, Gasparini S, Santinelli A, Scartozzi M, Valeri G, Giovagnoni A, Giuseppetti GM, Fabris G, Marmorale C, Fianchini A, Cascinu S: Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers. Lung Cancer 2005, 49:371-376.
• [18]Peñalver JC, Padilla J, Jordá C, Escrivá J, Cerón J, Calvo V, García A, Pastor J, Blasco E: Use of blood products in patients treated surgically for stage I non-small cell lung cancer. Arch Bronconeumol 2005, 41:484-488.
• [19]Chen J, Jiao S: The relationship between prognosis and per ioper ative allogenenic blood transfusions in 280 non- small cell lung cancer patients. Chin J Clin Oncol 2007, 34:632-635.
• [20]Thomas P, Michelet P, Barlesi F, Thirion X, Doddoli C, Giudicelli R, Fuentes P: Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies. Eur Respir J 2007, 29:565-570.
• [21]Panagopoulos ND, Karakantza M, Koletsis E, Apostolakis E, Sakellaropoulos GC, Filos KS, Eleni T, Dougenis D: Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for nonsmall cell lung cancer. Lung Cancer 2008, 62:273-280.
• [22]Ng T, Ryder BA, Chern H, Sellke FW, Machan JT, Harrington DT, Cioffi WG: Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer. J Thorac Cardiovasc Surg 2012, 143:815-819.
• [23]Cata JP, Chukka V, Wang H, Feng L, Gottumukkala V, Martinez F, Vaporciyan AA: Perioperative blood transfusions and survival in patients with non-small cell lung cancer: a retrospective study. BMC Anesthesiol 2013, 13:42. BioMed Central Full Text
• [24]Burrows L, Tartter P: Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 1982, 2:662.
• [25]Chung M, Steinmetz OK, Gordon PH: Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 1993, 80:427-432.
• [26]Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, Zhou Y, Zhou Y, Zhang Y: Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS One 2013, 8:e64261.
• [27]Blajchman MA, Bordin JO: The tumor growth-promoting effect of allogeneic blood transfusions. Immunol Invest 1995, 24:311-317.
• [28]Coussens LM, Werb Z: Inflammation and cancer. Nature 2002, 420:860-867.
• [29]Stephenson KR1, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH, Chang AE: Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 1988, 208:679-687.
• [30]Amato A, Pescatori M: Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006., 1CD005033
• [31]Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI: Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. British J Anaesth 2013, 110:690-701.